Enovis (ENOV) Competitors

Enovis (NYSE:ENOV) and Penumbra (NYSE:PEN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk.

Which has more volatility & risk, ENOV or PEN?

Enovis has a beta of 1.94, meaning that its stock price is 94% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500.

Do analysts recommend ENOV or PEN?

Enovis currently has a consensus price target of $65.86, suggesting a potential upside of 37.83%. Penumbra has a consensus price target of $261.36, suggesting a potential downside of 4.70%. Given Enovis' stronger consensus rating and higher probable upside, research analysts plainly believe Enovis is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86
Penumbra	0 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.81

Which has stronger valuation & earnings, ENOV or PEN?

Penumbra has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$1.71B	1.56	-$33.26M	-$2.19	-21.82
Penumbra	$1.16B	9.04	$90.95M	$0.86	318.89

Do institutionals and insiders hold more shares of ENOV or PEN?

98.5% of Enovis shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 2.4% of Enovis shares are held by insiders. Comparatively, 5.0% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in ENOV or PEN?

Penumbra received 791 more outperform votes than Enovis when rated by MarketBeat users. Likewise, 80.31% of users gave Penumbra an outperform vote while only 61.70% of users gave Enovis an outperform vote.

Company	Underperform	Outperform
Enovis	Outperform Votes 29 61.70%	Underperform Votes 18 38.30%
Penumbra	Outperform Votes 820 80.31%	Underperform Votes 201 19.69%

Does the media favor ENOV or PEN?

In the previous week, Penumbra had 5 more articles in the media than Enovis. MarketBeat recorded 14 mentions for Penumbra and 9 mentions for Enovis. Enovis' average media sentiment score of 0.59 beat Penumbra's score of 0.36 indicating that Enovis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	1 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is ENOV or PEN more profitable?

Penumbra has a net margin of 2.97% compared to Enovis' net margin of -5.95%. Penumbra's return on equity of 8.99% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-5.95%	4.39%	2.80%
Penumbra	2.97%	8.99%	6.80%

Summary

Penumbra beats Enovis on 13 of the 19 factors compared between the two stocks.